Cellomics, Inc. develops and markets products in the field of cellomics to extend the advances in genomics and proteomics. The company develops an integrated product platform including high content screening products to measure the physical position and activity over time of cells and cellular components. Cellomics, Inc. integrates fluorescent reagents, kits, cell lines, multiparametric assays, informatics, cell analysis instrumentation, and cellular bioinformatics tools to achieve an applicable platform for users in the pharmaceutical industry. The company was formerly known as BioDx, Inc. and changed its name to Cellomics, Inc. in January 1998. Cellomics, Inc. was incorporated in 1995.